Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal

Cites (212)

Items 201–212 of 212

1. Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area
   Huibert D. Mansvelder, Zara M. Fagen, Ben Chang, Robert D. Mitchum, Daniel S. McGehee · 2007 · Biochemical Pharmacology
2. Acetylcholine release in interpeduncular nucleus following the stimulation of habenula
   Bhagavatula R. Sastry, Susan E. Zialkowski, Loretta M. Hansen, Joanne P. Kavanagh, Evelyn M. Evoy · 1979 · Brain Research
3. Understanding Drug Addiction: Implications for Treatment
   Alan I. Leshner · 1996 · Hospital Practice
4. Upregulation of Neuronal Nicotinic Receptor Subunits α4,β2,and α7 in Transgenic Mice Overexpressing Human Acetylcholinesterase
   Marie M. Svedberg, Anne‐Lie Svensson, Mary Kathrine Johnson · 2002 · Journal of Molecular Neuroscience
5. Prefrontal dopamine is directly involved in the anxiogenic interoceptive cue of pentylenetetrazol but not in the interoceptive cue of chlordiazepoxide in the rat
   Laus M. Broersen, F. Abbate, Matthijs G.P. Feenstra, Jan P.C. de Bruin, Rob P.W. Heinsbroek, Berend Olivier · 2000 · Psychopharmacology
6. Pharmacological and immunochemical characterization of α2* nicotinic acetylcholine receptors (nAChRs) in mouse brain
   Paul Whiteaker, Jennifer A. Wilking, Robert W. B. Brown, Robert J. Brennan, Allan C. Collins, Jon Martin Lindstrom, Jim Boulter · 2009 · Acta Pharmacologica Sinica
7. Alpha bungarotoxin-1.4 nm gold: a novel conjugate for visualising the precise subcellular distribution of alpha 7* nicotinic acetylcholine receptors
   Ian W. Jones, Jacques Barik, Michael J. O’Neill, Susan Wonnacott · 2003 · Journal of Neuroscience Methods
8. Acute effects of nicotine withdrawal syndrome in pilots during flight.
   George A. Giannakoulas, Angelos M. Katramados, Nikolaos Melas · 2003 · PubMed
9. Temporal stability and within-subject consistency of nicotine withdrawal symptoms
   James C. Tate, Ovide F. Pomerleau, Cynthia S. Pomerleau · 1993 · Journal of Substance Abuse
10. Smoking cessation in the workplace: Evaluation of relapse factors
    David M. Daughton, Dewolf Roberts, Kashinath D. Patil, Stephen I. Rennard · 1990 · Preventive Medicine
11. SPECIFIC DETECTION OF κ LIGHT CHAIN IN URIC ACID STONES
    Yoshihiro Hashimoto, Kenjiro Kohri, Yutaro Hayashi, Akihiko Moriyama, Masanori Iguchi, Kiyofumi Asai, Taiji Kato · 1997 · Life Sciences
12. Combined Administration of Agonist‐Antagonist as a Method of Regulating Receptor Activation
    Jed E. Rose, Edward D. Levin, Frédérique M. Behm · 1995 · Annals of the New York Academy of Sciences